As expected, B16-F10-OVA melanoma was only partially sensitive to anti-PD-1 therapy, moreover, the addition of ITK inhibitor treatment further improved tumor growth inhibition (Fig. 1B and C left) and animal survival (Fig. 1C right). This evidence concerns the gene ITK and melanoma.